Mycophenolate - Surface Ophthalmics
Alternative Names: Mycosol; Surf-101Latest Information Update: 12 Apr 2024
At a glance
- Originator Surface Ophthalmics
- Class Acyclic acids; Anti-inflammatories; Benzofurans; Eye disorder therapies; Fatty acids; Small molecules
- Mechanism of Action B cell modulators; Immunosuppressants; T lymphocyte modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Clinical Phase Unknown Dry eyes
Most Recent Events
- 14 Mar 2024 Clinical trials in Dry eyes (Topical) prior to March 2024 (Surface Ophthalmics pipeline, March 2024)
- 14 Mar 2024 Surface Ophthalmics plans a phase III trial for Dry eyes (Topical)